• Nelfinavir Mesylate: Advanced HIV-1 Protease Inhibitor Workf

  2026-05-09

  Nelfinavir Mesylate, a benchmark HIV-1 protease inhibitor, is transforming both antiretroviral HIV research and the study of regulated cell death. This article details actionable workflows, cutting-edge applications, and troubleshooting strategies, leveraging the latest insights in proteostasis and ferroptosis.

• Chlorpromazine: Advancing Hepatic Nanointeraction Research

  2026-05-09

  Explore how chlorpromazine hydrochloride, beyond its canonical CNS use, is catalyzing breakthroughs in hepatic cellular interaction and nanoparticle biodistribution research. This article delivers mechanistic insight, protocol guidance, and strategic vision for translational scientists, contextualized by the latest evidence and APExBIO's high-purity reagent.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate:

  2026-05-08

  This study reports a robust 13-step synthesis of deuterium-labeled degarelix acetate, a critical internal standard for clinical pharmacokinetic studies of GnRH antagonists. The method leverages D2O/D3PO4 as the deuterium source, achieving high isotopic purity and practical yield, with implications for advancing precision in androgen-related disease research.

• SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin

  2026-05-07

  The referenced study demonstrates that SEMA3E promotes beige adipocyte differentiation and thermogenesis through β-catenin signaling in murine models. These findings advance the mechanistic understanding of adipose tissue plasticity and highlight new avenues for metabolic disease research.

• (1S,3R)-RSL3 as a Precision Ferroptosis Probe in Redox Aging

  2026-05-07

  (1S,3R)-RSL3, a potent glutathione peroxidase 4 inhibitor, enables precise dissection of ferroptosis and redox vulnerabilities in aging and cancer. This article uniquely bridges cutting-edge discoveries on lens epithelial susceptibility and tumor synthetic lethality, providing practical assay guidance for advanced research.

• Hepatic sEH Drives Osteoclastogenesis via Nrf2 Suppression i

  2026-05-06

  This study uncovers a novel liver-bone axis wherein hepatic soluble epoxide hydrolase (sEH) exacerbates osteoclast differentiation and osteoporosis by suppressing the Nrf2 antioxidant pathway. These findings advance mechanistic understanding of redox imbalance in bone disease and highlight new opportunities for targeted signaling pathway modulation.

• SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin

  2026-05-06

  This study uncovers SEMA3E as a key regulator of beige adipocyte differentiation and thermogenesis through β-catenin signaling in mice. The findings clarify molecular mechanisms of adipose browning with implications for metabolic disease research and PPARγ-targeted interventions.

• Single-Cell Insights into Ciprofloxacin-Tetracycline Antagon

  2026-05-05

  This study reveals that the antagonistic interaction between ciprofloxacin hydrochloride and tetracycline arises from suppression of bacterial cell death, as shown by single-cell microfluidic analysis. The findings advance understanding of antibiotic combination effects, emphasizing the need for single-cell quantification in optimizing antibacterial strategies.

• Exosomal Egr2 from BMSCs Regulates RNF8/DAPK1 in Ischemic St

  2026-05-05

  This study uncovers how exosomal Egr2, secreted by bone marrow-derived mesenchymal stem cells (BMSCs), mitigates neuronal injury in an ischemic stroke model by modulating the RNF8/DAPK1 axis. The findings illuminate a mechanistic pathway linking exosome-mediated gene regulation to neuroprotection, with practical implications for protein-protein interaction analysis in neurobiology.

• Chlorpromazine in Translational Research: Mechanisms, Models

  2026-05-04

  This thought-leadership article examines chlorpromazine’s evolving role in translational research, spanning its foundational use in dopamine receptor signaling models to innovative intersections with hepatic nanoparticle interactions. Drawing on recent mechanistic evidence and APExBIO’s high-purity chlorpromazine, we offer strategic guidance for experimentalists navigating the complexities of antipsychotic and antiemetic pathway modeling across neural and hepatic domains.

• Influenza Hemagglutinin (HA) Peptide: Precision in Protein T

  2026-05-04

  Explore the Influenza Hemagglutinin (HA) Peptide as a high-purity, quantitative tool for protein tagging and competitive immunoprecipitation. This article reveals deep mechanistic insights and practical protocols, bridging advanced protein interaction studies with next-generation assay optimization.

• HyperScript III RT SuperMix: Precision Reverse Transcription

  2026-05-03

  HyperScript III RT SuperMix unlocks high-efficiency cDNA synthesis from challenging RNA inputs, streamlining workflows for sensitive, reproducible gene expression analysis by qPCR. Its integrated gDNA wiper ensures robust results in clinical and translational research, including the detection of low-abundance and high-GC transcripts.

• Gramine Induces Ferroptosis in Triple-Negative Breast Cancer

  2026-05-02

  This study identifies Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) as a novel ferroptosis inducer that suppresses triple-negative breast cancer through CUL3-mediated MTDH ubiquitination. The mechanistic insights and validated preclinical models highlight Gramine's promise as a research tool for dissecting ferroptosis pathways in aggressive cancer subtypes.

• SIRT1/2 Inhibitor IV (cambinol): Mechanism and CNS Applicati

  2026-05-02

  SIRT1/2 Inhibitor IV (cambinol) is a cell-permeable, small-molecule inhibitor targeting NAD-dependent deacetylases SIRT1 and SIRT2. It enables precise modulation of metabolic and epigenetic pathways in cancer and CNS injury models. Cambinol's validated effects on p53 acetylation and astrocyte polarization make it a critical tool for translational research.

• Olive Biophenols Mitigate Amyloid Pathology in AD Models

  2026-05-01

  This study demonstrates that olive-derived biophenols, notably oleuropein, verbascoside, and rutin, can reduce amyloid beta-induced toxicity in SH-SY5Y cells and amyloid plaque burden in APPswe/PS1dE9 transgenic mice. The findings support the therapeutic potential of natural polyphenols in Alzheimer's disease and highlight the need for further investigation into their mechanisms and pharmacokinetics.

16660 records 1/1111 page Next 12345 下5页 Last page